These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 21182458)

  • 1. A greater prevalence of X4 viruses in HIV type 1 intravenous drug users reflects a "CD4+ effect".
    Monno L; Scudeller L; Ladisa N; Maggi P; Angarano G
    AIDS Res Hum Retroviruses; 2011 Oct; 27(10):1029-31. PubMed ID: 21182458
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of X4 tropic viruses in patients recently infected with HIV-1 and lack of association with transmission of drug resistance.
    de Mendoza C; Rodriguez C; García F; Eiros JM; Ruíz L; Caballero E; Aguilera A; Leiva P; Colomina J; Gutierrez F; del Romero J; Aguero J; Soriano V;
    J Antimicrob Chemother; 2007 Apr; 59(4):698-704. PubMed ID: 17327295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.
    Waters L; Mandalia S; Randell P; Wildfire A; Gazzard B; Moyle G
    Clin Infect Dis; 2008 May; 46(10):1617-23. PubMed ID: 18419499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV and risk of venous thromboembolism: a Danish nationwide population-based cohort study.
    Rasmussen LD; Dybdal M; Gerstoft J; Kronborg G; Larsen CS; Pedersen C; Pedersen G; Jensen J; Pedersen L; Sørensen HT; Obel N
    HIV Med; 2011 Apr; 12(4):202-10. PubMed ID: 20726905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-receptor switch during HAART is independent of virological success.
    Saracino A; Monno L; Cibelli DC; Punzi G; Brindicci G; Ladisa N; Tartaglia A; Lagioia A; Angarano G
    J Med Virol; 2009 Dec; 81(12):2036-44. PubMed ID: 19856465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High plasma HIV load in the CRF01-AE outbreak among injecting drug users in Finland.
    Kivelä PS; Krol A; Salminen MO; Geskus RB; Suni JI; Anttila VJ; Liitsola K; Zetterberg V; Miedema F; Berkhout B; Coutinho RA; Ristola MA
    Scand J Infect Dis; 2005; 37(4):276-83. PubMed ID: 15871166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV prevalence and risk behaviors of male injection drug users in Cairo, Egypt.
    Soliman C; Rahman IA; Shawky S; Bahaa T; Elkamhawi S; El Sattar AA; Oraby D; Khaled D; Feyisetan B; Salah E; El Taher Z; El Sayed N
    AIDS; 2010 Jul; 24 Suppl 2():S33-8. PubMed ID: 20610946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and correlates of infection with human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among drug users in Italy: a cross-sectional study.
    Camoni L; Regine V; Salfa MC; Nicoletti G; Canuzzi P; Magliocchetti N; Rezza G; Suligoi B;
    Scand J Infect Dis; 2009; 41(6-7):520-3. PubMed ID: 19415569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatitis and HIV infection in users of illegal drugs].
    Scheitlin T; Joller-Jemelka HI; Grob PJ
    Schweiz Med Wochenschr; 1992 Sep; 122(39):1432-45. PubMed ID: 1411402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombocytopenia in HIV-infected patients, Islamic Republic of Iran.
    Alaei K; Alaei A; Mansoori D
    East Mediterr Health J; 2002 Nov; 8(6):758-64. PubMed ID: 15568453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and laboratory correlates of human immunodeficiency virus infection in a cohort of intravenous drug users from New York, NY.
    el-Sadr W; Goetz RR; Sorrell S; Joseph M; Ehrhardt A; Gorman JM
    Arch Intern Med; 1992 Aug; 152(8):1653-9. PubMed ID: 1353953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure rates to hepatitis C and G virus infections among HIV-infected patients: evidence of efficient transmission of HGV by the sexual route.
    Ramia S; Mokhbat J; Sibai A; Klayme S; Naman R;
    Int J STD AIDS; 2004 Jul; 15(7):463-6. PubMed ID: 15228731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 infection among injection and ex-injection drug users from Rio de Janeiro, Brazil: prevalence, estimated incidence and genetic diversity.
    Teixeira SL; Bastos FI; Telles PR; Hacker MA; Brigido LF; de F Oliveira CA; Bongertz V; Morgado MG
    J Clin Virol; 2004 Nov; 31(3):221-6. PubMed ID: 15465416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nevirapine/didanosine/lamivudine once daily in HIV-1-infected intravenous drug users.
    Staszewski S; Haberl A; Gute P; Nisius G; Miller V; Carlebach A
    Antivir Ther; 1998; 3 Suppl 4():55-6. PubMed ID: 10723511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of HIV infection among injecting drug users: indications for a lower rate of progression among those who have frequently borrowed injecting equipment.
    Mientjes GH; van Ameijden EJ; van den Hoek AJ; Goudsmit J; Miedema F; Coutinho RA
    AIDS; 1993 Oct; 7(10):1363-70. PubMed ID: 8267910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 X4/R5 co-receptor in viral reservoir during suppressive HAART.
    Soulié C; Marcelin AG; Ghosn J; Amellal B; Assoumou L; Lambert S; Duvivier C; Costagliola D; Katlama C; Calvez V
    AIDS; 2007 Oct; 21(16):2243-5. PubMed ID: 18090053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy.
    Wang C; Vlahov D; Galai N; Bareta J; Strathdee SA; Nelson KE; Sterling TR
    J Infect Dis; 2004 Sep; 190(6):1046-54. PubMed ID: 15319852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fifteen years of HIV surveillance among people who inject drugs: the Australian Needle and Syringe Program Survey 1995-2009.
    Topp L; Day CA; Iversen J; Wand H; Maher L;
    AIDS; 2011 Mar; 25(6):835-42. PubMed ID: 21192232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of antiretroviral therapy on viral tropism in HIV-infected patients followed longitudinally for over 5 years.
    Briz V; Poveda E; del Mar González M; Martín-Carbonero L; González-González R; Soriano V
    J Antimicrob Chemother; 2008 Feb; 61(2):405-10. PubMed ID: 18063598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The incidence of human immunodeficiency virus type-1 (HIV-1) infection in parenteral drug users].
    Aviñó Rico MJ; Hernández Aguado I; Pérez Hoyos S; García de la Hera M; Ruiz I; Bolumar Montrull F
    Med Clin (Barc); 1994 Mar; 102(10):369-73. PubMed ID: 8182982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.